Literature DB >> 10716264

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.

N Evangelou1, M M Esiri, S Smith, J Palace, P M Matthews.   

Abstract

We assessed axonal loss in the normal appearing white matter of the corpus callosum in postmortem brains of patients with multiple sclerosis, using quantitative measures of both axonal density and white matter atrophy. The calculated total number of axons was reduced significantly (mean +/- SD, 5.4 x 10(7) +/- 3.1 x 10(7)) compared with normal controls (11.6 x 10(7) +/- 2.2 x 10(7), p = 0.001) with a reduction both in axonal density (median, 34%; range, 16-56%; p = 0.004) and area (mean +/- SD: multiple sclerosis, 584 +/- 170 mm2; controls, 871 +/- 163 mm2; p = 0.004). These results confirm substantial axonal loss in the normal appearing white matter and demonstrate that measures of both axonal density and white matter volume are necessary to appreciate the full extent of axonal loss.

Entities:  

Mesh:

Year:  2000        PMID: 10716264

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  104 in total

1.  Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging.

Authors:  A C Guo; V L Jewells; J M Provenzale
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis.

Authors:  Bertrand Audoin; My Van Au Duong; Jean-Philippe Ranjeva; Danielle Ibarrola; Irina Malikova; Sylviane Confort-Gouny; Elisabeth Soulier; Patrick Viout; André Ali-Chérif; Jean Pelletier; Patrick J Cozzone
Journal:  Hum Brain Mapp       Date:  2005-03       Impact factor: 5.038

3.  Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy.

Authors:  Stephanie C Manson; Jacqueline Palace; Joseph A Frank; Paul M Matthews
Journal:  Exp Brain Res       Date:  2006-06-21       Impact factor: 1.972

Review 4.  Multiple sclerosis and Alzheimer disease through the looking glass of MR imaging.

Authors:  Giovanni B Frisoni; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

Review 5.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

6.  Human motor corpus callosum: topography, somatotopy, and link between microstructure and function.

Authors:  Mathias Wahl; Birgit Lauterbach-Soon; Elke Hattingen; Patrick Jung; Oliver Singer; Steffen Volz; Johannes C Klein; Helmuth Steinmetz; Ulf Ziemann
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

7.  Corticomotor organisation and motor function in multiple sclerosis.

Authors:  Gary W Thickbroom; Michelle L Byrnes; Sarah A Archer; Allan G Kermode; Frank L Mastaglia
Journal:  J Neurol       Date:  2005-03-06       Impact factor: 4.849

8.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Early anisotropy changes in the corpus callosum of patients with optic neuritis.

Authors:  M Bester; C Heesen; S Schippling; R Martin; X-Q Ding; B Holst; J Fiehler
Journal:  Neuroradiology       Date:  2008-05-06       Impact factor: 2.804

10.  Short-latency afferent inhibition predicts verbal memory performance in patients with multiple sclerosis.

Authors:  Laura Cucurachi; Paolo Immovilli; Franco Granella; Giovanni Pavesi; Luigi Cattaneo
Journal:  J Neurol       Date:  2008-10-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.